Abstract
An economic evaluation was conducted to investigate the cost-effectiveness of ferric carboxymaltose (FCM) for the treatment of iron deficiency anemia (IDA) in Chinese adult patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have